Lys-MDA (Lysine-MDA, N-(L-lysinamidyl)-3,4-methylenedioxyamphetamine) is a
substituted amphetamine
Substituted amphetamines, or simply amphetamines, are a chemical class, class of compounds based upon the amphetamine structure; it includes all derivative (chemistry), derivative compounds which are formed by replacing, or substitution reacti ...
derivative with
empathogen
Entactogens, also known as empathogens or connectogens, are a class of psychoactive drugs that induce the production of experiences of emotional communion, oneness, connectedness, emotional openness—that is, empathy—as particularly observe ...
ic effects, which acts as a
prodrug
A prodrug is a pharmacologically inactive medication or compound that, after intake, is metabolized (i.e., converted within the body) into a pharmacologically active drug. Instead of administering a drug directly, a corresponding prodrug can be ...
for
MDA
MDA, mda or variants may refer to:
Businesses and organizations Political parties
* Meghalaya Democratic Alliance (2003–2008), in India
* Meghalaya Democratic Alliance (2018–present), in India
* Movement for Democracy in Africa, in Burkina F ...
with a slower onset of effects and longer duration of action. Lys-MDA, along with the related derivative
Lys-MDMA
Lys-MDMA, or lysine-MDMA, also known as ''N''-(L-lysinamidyl)-MDMA, is a prodrug of MDMA which is being investigated for possible use as a pharmaceutical drug in the treatment of psychiatric disorders. Structurally, lys-MDMA is to MDMA as lisdexa ...
, are in early stage human
clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human subject research, human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel v ...
s as potential treatments for
treatment-resistant depression
Treatment-resistant depression (TRD) is often defined as major depressive disorder in which an affected person does not respond adequately to at least two different antidepressant medications at an adequate dose and for an adequate duration. Inad ...
and
post-traumatic stress disorder
Post-traumatic stress disorder (PTSD) is a mental disorder that develops from experiencing a Psychological trauma, traumatic event, such as sexual assault, domestic violence, child abuse, warfare and its associated traumas, natural disaster ...
. New
MDMA
3,4-Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy (tablet form), and molly (crystal form), is an empathogen–entactogenic drug with stimulant and minor Psychedelic drug, psychedelic properties. In studies, it has been used ...
prodrugs are in the development phase at
MiHKAL GmbH
MiHKAL GmbH, with MiHKAL being an acronym of Molecules I Have Known and Loved, is a Swiss pharmaceutical company that is developing psychedelics and entactogens as potential medicines. Matthias Grill is the founder and chief executive officer (CE ...
in Switzerland.
A
phase 1 clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human subject research, human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel v ...
comparing MDMA, MDA, Lys-MDMA, and Lys-MDA has been completed as of August 2024.
See also
*
Lisdexamfetamine
Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used as a treatment for attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge ...
*
Serdexmethylphenidate
Serdexmethylphenidate is a prodrug of dexmethylphenidate created by the pharmaceutical company Zevra Therapeutics. The compound was first approved by the FDA as one of the active ingredients in Azstarys for the treatment of attention deficit h ...
*
N-t-BOC-MDMA
''N''-''t''-BOC-MDMA is a chemical compound which can be both a synthetic precursor to, or a prodrug of the empathogenic drug MDMA. It was first identified in Australia in 2015 as a seizure by customs, and has subsequently been found in China, ...
References
{{Monoamine releasing agents
Designer drugs
Entactogens
Experimental entactogens
Methylenedioxyphenethylamines
Prodrugs
Psychedelic phenethylamines
Serotonin-norepinephrine-dopamine releasing agents
Substituted amphetamines